Country: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Fexofenadine hydrochloride
Opella Healthcare France SAS T/A Sanofi
R06A
Fexofenadine hydrochloride
30 milligram(s)
Film-coated tablet
ANTIHISTAMINES FOR SYSTEMIC USE
Not marketed
2004-02-10
PACKAGE LEAFLET: INFORMATION FOR THE USER TELFAST 30 MG FILM-COATED TABLETS Fexofenadine hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOUR CHILD STARTS TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for your child only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as your child’s. - If your child gets any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Telfast is and what it is used for 2. What you need to know before your child uses Telfast 3. How to use Telfast 4. Possible side effects 5. How to store Telfast 6. Content of the pack and other information 1. WHAT TELFAST IS AND WHAT IT IS USED FOR Telfast contains fexofenadine hydrochloride, which is a non-drowsy antihistamine. Telfast 30 mg is used in children 6 to 11 years old to relieve the symptoms that occur with hay fever (seasonal allergic rhinitis) such as sneezing, itchy, runny or blocked nose and itchy, red and watery eyes. 2. WHAT YOU NEED TO KNOW BEFORE YOUR CHILD USES TELFAST DO NOT USE TELFAST if your child is allergic to fexofenadine or any of the other ingredients of this medicine (listed in section 6) WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before using Telfast if: your child has liver or kidneys problems your child has or ever had heart disease, since this medicine may lead to a fast or irregular heart beat If any of these apply to your child, or if you are not sure, always tell your doctor before giving Telfast to your child. OTHER MEDICINES AND TELFAST Tell your doctor or pharmacist if your child is taking, has recently taken or might take any other medicines. If you are taking apalutamide (a medicine to treat prostate cancer), as the effect of fexofenadine may be Lestu allt skjalið
Health Products Regulatory Authority 25 August 2023 CRN00DR85 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Telfast 30 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 30 mg of fexofenadine hydrochloride, which is equivalent to 28 mg of fexofenadine. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Peach round film-coated tablet debossed with “03” on one side and a scripted “e” on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Telfast 30 mg is indicated in children aged 6 to 11 for the relief of symptoms associated with seasonal allergic rhinitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Paediatric population_ - _Children 6 to 11 years of age_ The recommended dose of fexofenadine hydrochloride in children aged 6 to 11 years is 30 mg twice daily. - _Children under 6 years of age_ The efficacy of fexofenadine hydrochloride has not been established in children under 6 years of age. _Special populations_ The safety and efficacy of fexofenadine hydrochloride in renally or hepatically impaired children have not been established (see section 4.4 Special Warnings and Precautions for Use). Studies conducted in adults in special risk groups (renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in adults. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE The safety and efficacy of fexofenadine hydrochloride in renally or hepatically impaired children have not been established (see section 4.2, Posology and Method of Administration). Fexofenadine hydrochloride should be administered with caution in these patients. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and p Lestu allt skjalið